Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 3.85M | $25.0M | 19.05% | -- | 2026-06-30 |
| ORBIMED ADVISORS LLC | 3.27M | $21.0M | 16.18% | -561.4K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.06M | $20.0M | 15.13% | +2.36M | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 2.68M | $17.0M | 13.26% | +266.3K | 2026-06-30 |
| Rosalind Advisors, Inc. | 1.96M | $12.0M | 9.68% | +425.0K | 2026-06-30 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.62M | $10.0M | 8.01% | +633.7K | 2026-06-30 |
| ACORN CAPITAL ADVISORS, LLC | 1.54M | $10.0M | 7.62% | -- | 2026-06-30 |
| DCF Advisers, LLC | 1.43M | $9.0M | 7.10% | +743.0K | 2026-06-30 |
| Sio Capital Management, LLC | 1.30M | $8.0M | 6.43% | -- | 2026-06-30 |
| Nan Fung Group Holdings Ltd | 987.2K | $6.0M | 4.88% | +527.2K | 2026-06-30 |
